The anti-CD40 antibody tegoprubart offers a tacrolimus-free immunosuppression option for preventing islet transplant ...

New ACC/AHA guidelines update management of adults with congenital heart defects but highlight the shortage of specialists ...

The subcutaneous formulation of the bispecific antibody reduces treatment time to 1 minute vs 2-4 hours with IV infusion.

A multinational team revises the SOFA score to reflect modern organ support, validates it across diverse ICUs, and guides ...

Initiation of incretin receptor agonists vs SGLT2 inhibitors in adults with obesity, T2D, and obstructive sleep apnea is ...

New data show sharp rises in gonorrhea, syphilis, and chlamydia, alongside major gaps in testing, treatment, and surveillance ...

About 1 in 10 adults aged 70 or older may be eligible for anti-amyloid therapy, finds the first population-based study to use ...

Turns out, if there’s a health professional in the family, health outcomes tend to improve, according to a 2019 Swedish study ...

Researchers report links between third-trimester exposure to endocrine disruptors and higher behavioural risk scores in early childhood.

Veterans face substantial delays in being diagnosed with transthyretin amyloid cardiomyopathy after a heart failure diagnosis, with most facing delays longer than 6 months, a study finds.

Small-for-gestational-age births are more common among mothers with spondyloarthritis than in the general population; other adverse pregnancy outcomes are comparable.

A single pill consisting of two or more medications may help improve outcomes in hypertension, according to a new American ...